Vol 6, No 15 (August 08, 2018): Annals of Translational Medicine (Focus on "Cardiovascular Disease and Cardiometabolic Risk: Advances in Understanding Pathophysiology, Public Health Burden and Clinical Care")

Preface on Cardiovascular Disease and Cardiometabolic Risk: Advances in Understanding Pathophysiology, Public Health Burden and Clinical Care1

Global perspectives on cardiometabolic risk and cardiovascular disease: from basic science to bedside
Keith C. Ferdinand
Annals of Translational Medicine
 2018;
6
(15)
:290

Review Article on Cardiovascular Disease and Cardiometabolic Risk: Advances in Understanding Pathophysiology, Public Health Burden and Clinical Care1

Hypertension genomics and cardiovascular prevention
Fu Liang Ng, Helen R. Warren, Mark J. Caulfield
Annals of Translational Medicine
 2018;
6
(15)
:291
Creatine kinase, energy reserve, and hypertension: from bench to bedside
Lizzy M. Brewster
Annals of Translational Medicine
 2018;
6
(15)
:292

Original Article on Cardiovascular Disease and Cardiometabolic Risk: Advances in Understanding Pathophysiology, Public Health Burden and Clinical Care1

Improved identification of secondary hypertension: use of a systematic protocol
Carol Kotliar, Sebastián Obregón, Martin Koretzky, Fernando Botto, Ana Di Leva, Marcelo Boscaro, Ayan Ali, Keith C. Ferdinand
Annals of Translational Medicine
 2018;
6
(15)
:293

Editorial on Cardiovascular Disease and Cardiometabolic Risk: Advances in Understanding Pathophysiology, Public Health Burden and Clinical Care1

Advances in resistant hypertension
David A. Calhoun
Annals of Translational Medicine
 2018;
6
(15)
:294
Cardio-metabolic disease in India—the up-coming tsunami
Uday Mahadeo Jadhav
Annals of Translational Medicine
 2018;
6
(15)
:295

Review Article on Cardiovascular Disease and Cardiometabolic Risk: Advances in Understanding Pathophysiology, Public Health Burden and Clinical Care1

Unique approaches to hypertension control in China
Ji-Guang Wang
Annals of Translational Medicine
 2018;
6
(15)
:296

Editorial on Cardiovascular Disease and Cardiometabolic Risk: Advances in Understanding Pathophysiology, Public Health Burden and Clinical Care1

Hypertension and cardiovascular disease in the sub-Saharan African context
Yackoob Seedat, Ayan Ali, Keith C. Ferdinand
Annals of Translational Medicine
 2018;
6
(15)
:297

Perspective on Cardiovascular Disease and Cardiometabolic Risk: Advances in Understanding Pathophysiology, Public Health Burden and Clinical Care1

The economic case for US hospitals to revise their approach to heart failure readmission reduction
Armineh Zohrabian, Julie M. Kapp, Eduardo J. Simoes
Annals of Translational Medicine
 2018;
6
(15)
:298

Review Article on Cardiovascular Disease and Cardiometabolic Risk: Advances in Understanding Pathophysiology, Public Health Burden and Clinical Care1

Current concepts in the management of stable ischemic heart disease and acute coronary syndrome in patients with hemophilia
Ahmad Y. Jabbar, Hassan Baydoun, Maissaa Janbain, Keith C. Ferdinand
Annals of Translational Medicine
 2018;
6
(15)
:299

Original Article on Cardiovascular Disease and Cardiometabolic Risk: Advances in Understanding Pathophysiology, Public Health Burden and Clinical Care1

Physiologic assessment of moderate coronary lesions: a step towards complete revascularization in coronary artery bypass grafting
John C. Moscona, Jason D. Stencel, Gregory Milligan, Christopher Salmon, Rohit Maini, Paul Katigbak, Qusai Saleh, Ryan Nelson, Sudesh Srivastav, Owen Mogabgab, Rohan Samson, Thierry Le Jemtel
Annals of Translational Medicine
 2018;
6
(15)
:300

Review Article on Cardiovascular Disease and Cardiometabolic Risk: Advances in Understanding Pathophysiology, Public Health Burden and Clinical Care1

Neurohormonal modulation as therapeutic avenue for right ventricular dysfunction in pulmonary artery hypertension: till the dawn, waiting
Roy Emanuel, Astha Chichra, Nirav Patel, Thierry H. Le Jemtel, Abhishek Jaiswal
Annals of Translational Medicine
 2018;
6
(15)
:301

Original Article

Tumor stress-induced phosphoprotein 1 as a prognostic biomarker for breast cancer
Ruxing Wu, Fei Liu, Ping Peng, Hong Qiu, Huihua Xiong, Shiying Yu, Xiaoyuan Huang, Hanwang Zhang, Liang Zhuang
Annals of Translational Medicine
 2018;
6
(15)
:302
Prognostic value of circumferential resection margin in T3N0M0 esophageal squamous cell carcinoma
Yu-Shang Yang, Yun-Cang Wang, Han-Yu Deng, Yong Yuan, Zhi-Qiang Wang, Du He, Long-Qi Chen
Annals of Translational Medicine
 2018;
6
(15)
:303
Prolonged dexmedetomidine infusion in critically ill adult patients: a retrospective analysis of a large clinical database Multiparameter Intelligent Monitoring in Intensive Care III
Yue Zhao, Huaqiang Zhou, Wulin Tan, Yiyan Song, Zeting Qiu, Si Li, Shaowei Gao, Wenqi Huang
Annals of Translational Medicine
 2018;
6
(15)
:304
Thyroid stimulating hormone and free triiodothyronine are valuable predictors for diabetic nephropathy in patient with type 2 diabetes mellitus
Xianming Fei, Mingfen Xing, Mingyi Wo, Huan Wang, Wufeng Yuan, Qinghua Huang
Annals of Translational Medicine
 2018;
6
(15)
:305
Two novel mutations in parE among Shigella flexneri isolated from Jiangsu Province of China, 2016
Cun Xue, Jinchi Cai, Haiquan Kang, Ying Chen, Kaixuan Wang, Huimin Qian, Changjun Bao, Na Li, Zhen Guo, Zheng Zhang, Jing Wang, Ping Ma, Bing Gu
Annals of Translational Medicine
 2018;
6
(15)
:306

Case Report

Autologous platelet-rich gel combined with in vitro amplification of bone marrow mesenchymal stem cell transplantation to treat the diabetic foot ulcer: a case report
Qinan Wu, Xiaotian Lei, Liu Chen, Yanling Zheng, Hongmei Huang, Cheng Qian, Ziwen Liang
Annals of Translational Medicine
 2018;
6
(15)
:307

Big-data Clinical Trial Column2

Decision curve analysis: a technical note
Zhongheng Zhang, Valentin Rousson, Wen-Chung Lee, Cyril Ferdynus, Mingyu Chen, Xin Qian, Yizhan Guo, written on behalf of AME Big-Data Clinical Trial Collaborative Group
Annals of Translational Medicine
 2018;
6
(15)
:308

Liver News Column3

The usefulness of transient elastography in patients with autoimmune hepatitis—when can we use it?
Nahum Méndez-Sánchez, Xingshun Qi
Annals of Translational Medicine
 2018;
6
(15)
:309

Editorial

Overcoming the limitations of glomerular filtration rate estimation by using a novel rapid bedside measurement?
Guido Filler, Carmen Rodriguez Cuellar, Mara Medeiros
Annals of Translational Medicine
 2018;
6
(15)
:312
Pompe disease: how to solve many problems with one solution
Rosa Puertollano, Nina Raben
Annals of Translational Medicine
 2018;
6
(15)
:313

Perspective

Interactive translational research model and cadaveric simulation: where minimally invasive cardiac surgery and industry meet
Davida A. Robinson, Jessie H. Evans, Angelo J. Martellaro, Carl A. Johnson Jr, Jude S. Sauer, Peter A. Knight
Annals of Translational Medicine
 2018;
6
(15)
:314

Disclosure:

1. The series “Cardiovascular Disease and Cardiometabolic Risk: Advances in Understanding Pathophysiology, Public Health Burden and Clinical Care” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding. Keith C. Ferdinand served as the unpaid Guest Editor for the series.

2. The series “Big-data Clinical Trial Column” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding.

3. The series “Liver News Column” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding.

4. The series “Meet Medical Professionals in Sydney” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding.